Explore / Clinical trial
Clinical trial

Pilot Study of RR-HNK in OCD

Carolyn RodriguezRecruitingPhase 1Started Jan 23, 202645 enrolledUnited StatesNCT06575075

Abstract

The purpose of this study is to understand how RR-HNK works in the brain to bring about a reduction in OCD symptoms.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineOCD

Keywords

AMPA receptor antagonisthydroxynorketamineketamine metaboliteObsessive-Compulsive Disorder

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.